PCSK9 INHIBITOR EVOLOCUMAB REDUCES CARDIOTOXICITYAND INFLAMMATION INDUCED BY DOXORUBICIN-HER2 BLOCKING AGENT SEQUENTIAL TREATMENT THROUGH MYD88/NF-KB/MTORC1 PATHWAYS
EUROPEAN HEART JOURNAL SUPPLEMENTS（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要